Stocks and Investing
Stocks and Investing
Wed, July 17, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Matthew Sykes Maintained (wgs) at Hold with Increased Target to $28 on, Jul 17th, 2024
Matthew Sykes of Goldman Sachs, Maintained "GeneDx Holdings Corp." (WGS) at Hold with Increased Target from $13 to $28 on, Jul 17th, 2024.
Matthew has made no other calls on WGS in the last 4 months.
There are 3 other peers that have a rating on WGS. Out of the 3 peers that are also analyzing WGS, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Matthew
- Bill Bonello of "Craig-Hallum" Initiated at Strong Buy and Held Target at $43 on, Wednesday, July 10th, 2024
- Mark Massaro of "BTIG" Maintained at Strong Buy with Increased Target to $35 on, Wednesday, June 26th, 2024
- Dan Brennan of "TD Cowen" Maintained at Strong Buy with Increased Target to $24 on, Tuesday, April 30th, 2024
Contributing Sources